Design and Synthesis of New 1,3‐Benzdiazinan‐4‐one Derivatives as Selective Cyclooxygenase (COX‐2) Inhibitors

Afshin Zarghi, Tannaz Zebardast, Fatemeh Hajighasemali, Eskandar Alipoor, Bahram Daraie, Mehdi Hedayati

Archiv der Pharmazie · 2011 · 12 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

A new group of regioisomeric 2,3-diaryl-1,3-benzdiazinan-4-ones, possessing a methyl sulfonyl pharmacophore, were synthesized and their biological activities were tested for cyclooxygenase-2 (COX-2) inhibitory activity. In vitro COX-1/COX-2 inhibition studies identified 3-(p-fluorophenyl)-2-(4-methylsulfonylphenyl)-1,3-benzdiazinane-4-one (2b) as a potent and highly selective (IC(50) = 0.07 µM; selectivity index = 572.8) COX-2 inhibitor.

References

12